Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "Triptan" receptors: Implications in migraine

Journal of Neuroscience

Volumn 33, Issue 37, 2013, Pages 14869-14877

  Akerman, Simon ^a   Holland, Philip R ^a   Lasalandra, Michele P ^a   Goadsby, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; BICUCULLINE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; GRI 27935; RIMONABANT; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN STEM; CONTROLLED STUDY; EVOKED CORTICAL RESPONSE; MALE; MENINGEAL ARTERY; MICROINJECTION; MIGRAINE; NERVE STIMULATION; NOCICEPTION; NONHUMAN; PAIN RECEPTOR; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; RECEPTIVE FIELD; SOMATOSENSORY CORTEX; STIMULATION; TRIGEMINAL NERVE;

ANIMALS; ARACHIDONIC ACIDS; BICUCULLINE; CANNABINOID RECEPTOR AGONISTS; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; GABA-A RECEPTOR ANTAGONISTS; MALE; MICROINJECTIONS; NERVE FIBERS, MYELINATED; PAIN; PERIAQUEDUCTAL GRAY; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTOR, CANNABINOID, CB1; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS; SKIN; TRIGEMINAL NUCLEI;

EID: 84883731858     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0943-13.2013     Document Type: Article

References (42)

1. Akerman S, Kaube H, Goadsby PJ (2004) Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 309:56-63. CrossRef Medline
2. Akerman S, Holland PR, Goadsby PJ (2007) Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. J Pharmacol Exp Ther 320: 64-71. Medline
3. Akerman S, Holland PR, Goadsby PJ (2011) Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 12:570-584. CrossRef Medline
4. Bartsch T, Knight YE, Goadsby PJ (2004) Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol 56:371-381. CrossRef Medline
5. Bergerot A, Holland PR, Akerman S, Bartsch T, Ahn AH, MaassenVanDen-Brink A, Reuter U, Tassorelli C, Schoenen J, Mitsikostas DD, van den Maagdenberg AM, Goadsby PJ (2006) Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci 24:1517-1534. CrossRef Medline
6. Bernstein C, Burstein R (2012) Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol 8:89-99. CrossRef Medline
7. Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964-982. Medline
8. Cumberbatch MJ, Hill RG, Hargreaves RJ (1998) Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses. Cephalalgia 18:659-663. CrossRef Medline
9. Cupini LM, Costa C, Sarchielli P, Bari M, Battista N, Eusebi P, Calabresi P, Maccarrone M (2008) Degradation of endocannabinoids in chronic migraine and medication overuse headache. Neurobiol Dis 30:186-189. CrossRef Medline
10. de Novellis V, Mariani L, Palazzo E, Vita D, Marabese I, Scafuro M, Rossi F, Maione S (2005) Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience 134:269-281. CrossRef Medline
11. Field A (2005) Discovering statistics using SPSS, Ed 2. London: Sage.
12. Fields HL, Heinricher MM (1985) Anatomy and physiology of a nociceptive modulatory system. Philos Trans R Soc Lond B Biol Sci 308:361-374. CrossRef Medline
13. Fields HL, Vanegas H, Hentall ID, Zorman G (1983) Evidence that disinhibition of brain stem neurones contributes to morphine analgesia. Nature 306:684-686. CrossRef Medline
14. Finn DP, Jhaveri MD, Beckett SR, Roe CH, Kendall DA, Marsden CA, Chapman V (2003) Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology 45:594-604. CrossRef Medline
15. Goadsby PJ, Hoskin KL (1996) Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain 67:355-359. CrossRef Medline
16. Goadsby PJ, Knight Y (1997) Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors. Br J Pharmacol 122: 918-922. CrossRef Medline
17. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine-a current understanding and treatment. N Engl J Med 346:257-270. CrossRef Medline
18. Greco R, Gasperi V, Sandrini G, Bagetta G, Nappi G, Maccarrone M, Tassorelli C (2010) Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat. Cephalalgia 30: 296-302. Medline
19. Haj-Dahmane S, Shen RY (2009) Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors. J Pharmacol Exp Ther 331: 186-196. CrossRef Medline
20. Hu JW, Dostrovsky JO, Sessle BJ (1981) Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). I. Responses to oral-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus oralis. J Neurophysiol 45:173-192. Medline
21. Jeong HJ, Chenu D, Johnson EE, Connor M, Vaughan CW (2008) Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain 4:54. CrossRef Medline
22. Katona I, Freund TF (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14:923-930. CrossRef Medline
23. Kawahara H, Drew GM, Christie MJ, Vaughan CW (2011) Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. Br J Pharmacol 163:1214-1222. CrossRef Medline
24. Kelly S, Chapman V (2001) Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J Neurophysiol 86:3061-3064. Medline
25. Knight YE, Goadsby PJ (2001) The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience 106: 793-800. CrossRef Medline
26. Knight YE, Bartsch T, Kaube H, Goadsby PJ (2002) P/Q-type calciumchannel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci 22:RC213. Medline
27. Knight YE, Bartsch T, Goadsby PJ (2003) Trigeminal antinociception induced by bicuculline in the periaqueductal gray (PAG) is not affected by PAG P/Q-type calcium channel blockade in rat. Neurosci Lett 336:113-116. CrossRef Medline
28. Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V (2006) Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. J Pharmacol Exp Ther 316:969-982. Medline
29. Meng ID, Johansen JP (2004) Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist. Neuroscience 124:685-693. CrossRef Medline
30. Meng ID, Manning BH, Martin WJ, Fields HL (1998) An analgesia circuit activated by cannabinoids. Nature 395:381-383. CrossRef Medline
31. Millan MJ (1999) The induction of pain: an integrative review. Prog Neurobiol 57:1-164. CrossRef Medline
32. Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355-474. CrossRef Medline
33. Palazzo E, Marabese I, de Novellis V, Oliva P, Rossi F, Berrino L, Maione S (2001) Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Neuropharmacology 40:319-326. CrossRef Medline
34. Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D, Giordano C, Di Marzo V, Mangoni GS, Rossi F, Maione S (2006) Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Eur J Neurosci 24: 2011-2020. CrossRef Medline
35. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, Ed 4. London: Academic.
36. Rossi C, Pini LA, Cupini ML, Calabresi P, Sarchielli P (2008) Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol 64:1-8. CrossRef Medline
37. Sarchielli P, Pini LA, Coppola F, Rossi C, Baldi A, Mancini ML, Calabresi P (2007) Endocannabinoids in chronic migraine: CSF findings suggest a system failure. Neuropsychopharmacology 32:1384-1390. CrossRef Medline
38. Vaughan CW, McGregor IS, Christie MJ (1999) Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. Br J Pharmacol 127:935-940. CrossRef Medline
39. Vaughan CW, Connor M, Bagley EE, Christie MJ (2000) Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol 57:288-295. Medline
40. Waters AJ, Lumb BM (1997) Inhibitory effects evoked from both the lateral and ventrolateral periaqueductal grey are selective for the nociceptive responses of rat dorsal horn neurones. Brain Res 752:239-249. CrossRef Medline
41. Waters AJ, Lumb BM (2008) Descending control of spinal nociception from the periaqueductal grey distinguishes between neurons with and without C-fibre inputs. Pain 134:32-40. CrossRef Medline
42. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110. CrossRef Medline